9 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
prevention - Comparison Table ... #Anticoagulation ... #VTE #Management ... #Pharmacology # ... Comparison #Table
Ketosis Disorders - Comparison Table
 • Starvation Ketosis
 • Alcoholic Ketoacidosis (AKA)
 • Diabetic Ketoacidosis (DKA)
Disorders - Comparison Table ... (AKA) • Diabetic ... Ketoacidosis (DKA ... differential #diagnosis #management ... endocrinology #comparison #table
Initial Anticoagulation for Venous Thromboembolism (VTE)

#Anticoagulation #Initial #Initiation #Dosing #Venous #Thromboembolism #VTE #Pharmacology #Table #Management
Initial Anticoagulation ... Thromboembolism (VTE ... ) #Anticoagulation ... #Pharmacology # ... Table #Management
Oral Anticoagulation Management Cheat Sheet: Warfarin, Apixaban, Dabigatran, Rivaroxaban
 - Mechanism of Action
 - Routine Blood
Oral Anticoagulation ... Management Cheat ... Anticoagulant #DOAC ... #Management #Table ... #Pharmacology #
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... - Dabigatran #anticoagulation ... #pharmacology # ... medications #doac ... #management #drugs
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
K antagonist (VKA ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC ... #Table #Replacement
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Perioperative Management ... patients on chronic anticoagulation ... per treatment table ... Perioperative #Management ... #Treatment #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Stable patients ... Anticoagulation ... Diabetes regimen ... • <3mo since VTE ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Management during ... Avoid Warfarin and DOAC ... Delivery • Stable ... suggest prophylactic anticoagulation ... Serial TTE and close